Apathy dimensions in Parkinson's disease
Ratko Radakovic1,2,3,4,5, Richard Davenport2, John M Starr3,5
1Human Cognitive Neuroscience, University of Edinburgh, Edinburgh, UK.
International Journal of Geriatric Psychiatry
|March 2, 2017
Summary
Parkinson's disease (PD) patients exhibit apathy, particularly in executive function and initiation, impacting daily living but not motor function. The Dimensional Apathy Scale (DAS) is a reliable tool for assessing this multidimensional symptom in PD.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Psychology
Background:
- Apathy is a significant and debilitating symptom in Parkinson's disease (PD).
- The multidimensional nature of apathy in PD requires further investigation.
- Understanding apathy's specific dimensions is crucial for effective management.
Purpose of the Study:
- To evaluate the psychometric properties of the Dimensional Apathy Scale (DAS) in Parkinson's disease patients.
- To explore the multidimensional apathy profile in individuals with PD.
- To establish the validity and reliability of the DAS as an assessment tool for apathy in PD.
Main Methods:
- A cohort of 34 PD patients and 34 healthy controls participated.
- Informants/carers (30 for each group) also completed apathy assessments.
- Participants completed the DAS, Apathy Evaluation Scale, and Geriatric Depression Scale Short Form.
Main Results:
- PD patients self-reported significantly higher apathy in executive and initiation dimensions compared to controls.
- Informant ratings indicated significantly higher executive apathy in PD patients versus controls.
- Apathy dimensions were associated with impaired daily living activities but not motor disability.
Conclusions:
- The Dimensional Apathy Scale (DAS) is a valid and reliable instrument for assessing multidimensional apathy in Parkinson's disease.
- Parkinson's disease is characterized by an executive apathy profile, as perceived by caregivers, and also involves initiation apathy reported by patients.
- These findings highlight a lack of motivation in planning, organization, attention, and initiation, warranting further research into cognitive underpinnings and clinical impact.
Related Concept Videos
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Negative and Cognitive Symptoms of Schizophrenia
836
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
836
Neural Regulation
43.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.9K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K


